Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1 Integron from Acinetobacter baumannii Clinical Isolates from Korea

K Lee, JH Yum, D Yong, HM Lee, HD Kim… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Carbapenem resistance mediated by acquired carbapenemase genes has been
increasingly reported, particularly for clinical isolates of Pseudomonas aeruginosa and …

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes

C Gudiol, F Tubau, L Calatayud… - Journal of …, 2011 - academic.oup.com
Objectives To assess the risk factors, antibiotic therapy and outcomes of multidrug-resistant
Gram-negative bacilli (MDRGNB) bacteraemia in hospitalized patients with cancer. Methods …

Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory

C Franklin, L Liolios, AY Peleg - Journal of clinical microbiology, 2006 - Am Soc Microbiol
Rapid detection of metallo-β-lactamase (MBL)-producing gram-negative pathogens is
critical to prevent their widespread dissemination. Thus far, no standardized phenotypic …

Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study

MV Edelstein, EN Skleenova… - The Lancet infectious …, 2013 - thelancet.com
Background Multidrug-resistant and extensively-drug-resistant Pseudomonas aeruginosa
are increasing therapeutic challenges worldwide. We did a longitudinal epidemiological and …

Acinetobacter baumannii: biology and drug resistance—role of carbapenemases

P Nowak, P Paluchowska - Folia histochemica et …, 2016 - journals.viamedica.pl
Acinetobacter baumannii is a Gram-negative, glucose-non-fermenting, oxidase-negative
coccobacillus, most commonly associated with the hospital settings. The ability to survive in …

Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies

I Abbott, GM Cerqueira, S Bhuiyan… - Expert review of anti …, 2013 - Taylor & Francis
Unprecedented levels of antimicrobial resistance in bacterial isolates have prompted great
concerns globally. In 2012 the WHO released a publication outlining the evolving threat of …

[HTML][HTML] Modified Hodge test: A simple and effective test for detection of carbapenemase production

A Amjad, IA Mirza, SA Abbasi, U Farwa… - Iranian journal of …, 2011 - ncbi.nlm.nih.gov
Modified Hodge test: A simple and effective test for detection of carbapenemase production -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study

A Salmanov, D Shchehlov, O Svyrydiuk, I Bortnik… - Journal of Hospital …, 2023 - Elsevier
Summary Background Healthcare-associated infections (HAIs) caused by multidrug-
resistant organisms (MDROs) have a high impact in terms of morbidity, mortality, and costs …

Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas …

G Samonis, S Maraki, DE Karageorgopoulos… - European journal of …, 2012 - Springer
Fosfomycin represents a potential last-resort treatment option for infections with certain
multidrug-resistant (MDR) Gram-negative pathogens. We evaluated double-drug …

Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients

M Bodro, N Sabé, F Tubau, L Lladó, C Baliellas… - …, 2013 - journals.lww.com
Background Although infections due to the six ESKAPE pathogens have recently been
identified as a serious emerging problem, information regarding bacteremia caused by …